Company: SWKH
Filing Date: 2025-03-20
Form Type: 10-K
Source: 0001628280-25-013989
Chunk: 126

Company: SWK Holdings Corp
Filing Date: 2025-03-20
Form: 10-K
Item: Item 1B
Chunk 126
---
 Restated Bylaws, dated as of  August 12, 2022.8-K3.0208/15/224.01Form of Specimen Common Stock CertificateS-1/A4.0109/21/994.02Description of Securities Registered Under Section 12 of the Exchange Act10-K4.0203/31/234.03Indenture dated as of October 3, 2023, between the Company and Wilmington Trust, National Association, as trustee.8-K4.110/03/234.04First Supplemental Indenture dated as of October 3, 2023, between the Company and Wilmington Trust, National Association, as trustee8-K4.210/03/234Form of 9.00% Senior Notes due 2027 (included as Exhibit A to 4.04 above)8-K4.2.110/03/2310.012010 Equity Incentive Plan, as amended.*DEF 14AAppendix A10/23/1910.02SWK Holdings Corporation 2010 Equity Incentive Plan Form of Restricted Stock Award Agreement.*10-Q10.211/09/1010.03Registration Rights Agreement, dated as of September 6, 2013, among Double Black Diamond, L.P., Double Black Diamond Offshore Ltd., Black Diamond Offshore, Ltd. and the Company8-K10.409/09/1310.04Employment Agreement, dated January 28, 2019, between the Company and Winston L. Black III.*8-K10.101/30/1910.05Royalty Agreement, dated April 2, 2013, among SWK Funding LLC, Bess Royalty, L.P. and InSite Vision Incorporated.**#S-1/A10.104/01/1410.06Stockholders’ Agreement, dated August 18, 2014, among Double Black Diamond Offshore Ltd., Black Diamond Offshore Ltd. and SWK Holdings Corporation8-K10.208/19/1410.07Amendment No. 1 to the Stockholders’ Agreement dated June 28, 20228-K10.106/29/2210.08Amendment No. 2 to the Stockholders’ Agreement dated February 27, 202310-K10.13/31/2310.09Royalty Agreement dated December 13, 2016, among SWK Funding LLC and Opiant Pharmaceuticals, Inc.